tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (DE:4XC1)
FRANKFURT:4XC1
Germany Market

KalVista Pharmaceuticals (4XC1) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
KalVista Pharmaceuticals’s (4XC1) Moving Averages Convergence Divergence (MACD) indicator is -0.15, suggesting KalVista Pharmaceuticals is a Buy.
KalVista Pharmaceuticals’s (4XC1) 20-Day exponential moving average is 12.69, while KalVista Pharmaceuticals’s (4XC1) share price is €12.4, making it a Sell.
KalVista Pharmaceuticals’s (4XC1) 50-Day exponential moving average is 12.60, while KalVista Pharmaceuticals’s (4XC1) share price is €12.4, making it a Sell.

KalVista Pharmaceuticals (4XC1) Pivot Points

Feb 17, 2026, 02:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.80
12.80
12.80
12.80
12.80
12.80
12.80
Fibonacci
12.80
12.80
12.80
12.80
12.80
12.80
12.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

KalVista Pharmaceuticals (4XC1) Moving Averages

Feb 17, 2026, 02:58 PM
Period
Simple
Exponential
MA5
12.40Sell
12.47Sell
MA10
12.62Sell
12.54Sell
MA20
12.73Sell
12.69Sell
MA50
13.05Sell
12.60Sell
MA100
11.62Buy
12.15Buy
MA200
11.46Buy
11.69Buy
KalVista Pharmaceuticals’s (4XC1) 10-Day exponential moving average is 12.54, while KalVista Pharmaceuticals’s (4XC1) share price is €12.4, making it a Sell.
KalVista Pharmaceuticals’s (4XC1) 100-Day exponential moving average is 12.15, while KalVista Pharmaceuticals’s (4XC1) share price is €12.4, making it a Buy.
KalVista Pharmaceuticals’s (4XC1) stock price is €12.4 and KalVista Pharmaceuticals’s (4XC1) 50-day simple moving average is 13.05, creating a Sell signal.
KalVista Pharmaceuticals’s (4XC1) stock price is €12.4 and KalVista Pharmaceuticals’s (4XC1) 100-day simple moving average is 11.62, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) stock price is €12.4 and KalVista Pharmaceuticals’s (4XC1) 200-day simple moving average is 11.46, creating a Buy signal.

KalVista Pharmaceuticals (4XC1) Technical Indicators

Feb 17, 2026, 02:58 PM
Name
Value
Implied Action
RSI (14)
47.25
Neutral
STOCH (9,6)
33.33
Neutral
STOCHRSI (14)
32.97
Neutral
MACD (12,26)
-0.15
Buy
ADX (14)
8.82
Buy
Williams %R
-71.43
Buy
CCI (14)
-43.66
Neutral
ATR (14)
0.46
-
Ultimate Oscillator
38.68
Neutral
ROC
-6.77
Sell
KalVista Pharmaceuticals’s (4XC1) Relative Strength Index (RSI) is 47.25, creating a Neutral signal.
KalVista Pharmaceuticals’s (4XC1) Trend Strength Indicator (ADX) is 8.82, creating a Buy signal.
KalVista Pharmaceuticals’s (4XC1) Commodity Channel Index (CCI) is -43.66, creating a Neutral signal.
KalVista Pharmaceuticals’s (4XC1) Price Rate of Change (ROC) is -6.77, creating a Sell signal.

FAQ

Is 4XC1 a Buy, Hold, or Sell?
Based on 4XC1’s technical indicators, 4XC1 is a Sell.
    What is 4XC1’s RSI (14)?
    4XC1’s RSI (14) is 47.25, which suggests 4XC1 is a Neutral.
      What is 4XC1’s MACD?
      4XC1’s MACD is -0.15, which suggests 4XC1 is a Buy.
        What is 4XC1’s 5-day moving average?
        4XC1’s 5-day moving average is 12.40, which suggests 4XC1 is a Sell.
          What is 4XC1’s 20-day moving average?
          4XC1 20-day moving average is 12.73, which suggests 4XC1 is a Sell.
            What is 4XC1’s 50-day moving average?
            4XC1’s 50-day moving average is 13.05, which suggests 4XC1 is a Sell.
              What is 4XC1’s 200-day moving average?
              4XC1’s 200-day moving average is 11.46, which suggests 4XC1 is a Buy.
                What is 4XC1’s Williams % R (14)?
                4XC1’s Williams % R (14) is -71.43, which suggests 4XC1 is a Buy.
                  What is 4XC1’s CCI (14)?
                  4XC1’s CCI (14) is -43.66, which suggests 4XC1 is a Neutral.
                    What is the share price of KalVista Pharmaceuticals?